bone marrow cells

DRUG2 trials

Sponsors

University of Milano Bicocca, European Institute of Oncology

Conditions

BCR-ABL PositiveChronicLeukemiaLeukemia, Myeloid, AcuteMyelogenousMyeloid DysplasiaOvarian Epithelial Cancer

Phase 2

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

CompletedNCT02638467

University of Milano BicoccaBCR-ABL Positive, Chronic, Leukemia +1

Start: 2015-11-30End: 2020-02-29Updated: 2020-11-05

Unknown Phase

Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors

RecruitingNCT06785077

European Institute of OncologyLeukemia, Myeloid, Acute, Myeloid Dysplasia, Ovarian Epithelial Cancer

Start: 2020-10-02End: 2028-04-30Target: 157Updated: 2025-01-20